Skip to content

Phathom Pharmaceuticals, Inc. PHAT Increase Decrease In Operating Right Of Use Asset And Lease Liabilities

Increase Decrease In Operating Right Of Use Asset And Lease Liabilities at other companies

Paycom Software logo
Paycom SoftwarePAYC
$1.4M+100%
Paycom Software logo
Paycom SoftwarePAYC
$1.4M+100%
Red Cat Holdings, Inc. logo
Red Cat Holdings, Inc.RCAT
-$163K-1,154%
ArcBest logo
ArcBestARCB
$34K-99.7%
SHO
Sunstone Hotel InvestorsSHO
-$217K-53.9%
GRAIL, Inc. logo
GRAIL, Inc.GRAL
-$182K+17.6%

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$824.68M+13.4%
Enterprise value$810.08M+12.7%
P/S-4.9×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept phat:IncreaseDecreaseInOperatingRightOfUseAssetAndLeaseLiabilities.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s increase decrease in operating right of use asset and lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s increase decrease in operating right of use asset and lease liabilities?
Phathom Pharmaceuticals, Inc. (PHAT) reported increase decrease in operating right of use asset and lease liabilities of $10K in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s increase decrease in operating right of use asset and lease liabilities changed year-over-year?
Phathom Pharmaceuticals, Inc.'s increase decrease in operating right of use asset and lease liabilities decreased by 75.0% year-over-year, from $40K to $10K.
What is the long-term trend for Phathom Pharmaceuticals, Inc.'s increase decrease in operating right of use asset and lease liabilities?
Over 3 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s increase decrease in operating right of use asset and lease liabilities has grown at a 31.3% compound annual growth rate (CAGR), from $98K to $222K.
What does increase decrease in operating right of use asset and lease liabilities mean?
This represents the net change in the balance sheet value of operating lease assets and their corresponding lease liabilities. It captures the impact of lease accounting standards on operating cash flows, excluding the actual cash portion of lease payments. This is essential for understanding the company's long-term fixed obligations and real estate or equipment footprint.